AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion - statnews.com

AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion  statnews.comEli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market  CNBCInsilico Medicine secures $2.75 billion drug collaboration with Eli Lilly  ReutersLilly inks $2.75B licensing, AI discovery deal with Insilico  FirstWord PharmaEli Lilly and Insilico sign an AI drug discovery deal, paying $115M upfront  endpoints.news